FGF2 and obesity disorder: In conclusion, evidence from genetic ablation and exogenous treatment in in vitro models ofadipocytes demonstrate, for the first time, that shed Sdc4 from adipocytes during obesity acts as a novel suppressor of lipolysis through the FGF2/FGFR1 axis.